Founded by US-returnee PhD scientists in 2023, Guangzhou Genis Biotech Co., Ltd. specializes in innovative in vitro diagnostic manufacturing. With dedicated R&D facilities in the United States and Guangzhou, Our business stretches across four major sectors: core raw materials, veterinary diagnostic products, human clinical IVD reagents and food safety testing supplies. Our human-use test menus range from respiratory, digestive and tropical infectious diseases to STDs, myocardial markers, tumor indicators and maternal-infant health assays.
We leverage mature platforms including hematology, lateral immunochromatography, fluorescent immunoassay, microfluidic coagulation testing and rapid parasite egg screening.
Guided by our commitment to accessible, high-quality healthcare, we operate under a customer-centric development model. Apart from standardized finished products, we provide comprehensive turnkey services: collaborative R&D, quality management system setup and full-cycle assistance covering product research, regulatory preparation and commercial launch. We consistently pursue technical innovation, outstanding product quality and ultimate client satisfaction.

Our business footprint spans more than 20 countries worldwide and has earned widespread acclaim from global clients. We are committed to delivering precise diagnostic testing solutions to help build a better quality of life for all.